{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pregabalin+300mg", "query": { "intervention": "Pregabalin 300mg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 20, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pregabalin+300mg&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-06T13:03:42.859Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04705480", "title": "Pregabalin vs. Gabapentin on Reducing Opioid Usage", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Analgesics", "Gabapentin", "Injuries", "Narcotics", "Pain", "Trauma" ], "interventions": [ { "name": "Pregabalin 50mg", "type": "DRUG" }, { "name": "Gabapentin 300mg", "type": "DRUG" }, { "name": "Neither Pregabalin nor Gabapentin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CAMC Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 109, "start_date": "2021-04-12", "completion_date": "2024-12-13", "has_results": true, "last_update_posted_date": "2026-01-06", "last_synced_at": "2026-09-06T13:03:42.859Z", "location_count": 1, "location_summary": "Charleston, West Virginia", "locations": [ { "city": "Charleston", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04705480" }, { "nct_id": "NCT04122196", "title": "Perioperative Pregabalin in Ureteroscopy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Kidney Stone", "Pain, Postoperative", "Addiction", "Opioid Use" ], "interventions": [ { "name": "Pregabalin 300mg", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Missouri-Columbia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 118, "start_date": "2020-06-01", "completion_date": "2024-07-01", "has_results": true, "last_update_posted_date": "2025-11-12", "last_synced_at": "2026-09-06T13:03:42.859Z", "location_count": 1, "location_summary": "Columbia, Missouri", "locations": [ { "city": "Columbia", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04122196" }, { "nct_id": "NCT02725112", "title": "Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Pregabalin ER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 25, "start_date": "2016-02-12", "completion_date": "2016-06-17", "has_results": false, "last_update_posted_date": "2021-01-20", "last_synced_at": "2026-09-06T13:03:42.859Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02725112" }, { "nct_id": "NCT03472469", "title": "MAST Trial: Multi-modal Analgesic Strategies in Trauma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Nonspecific Pain Post Traumatic Injury" ], "interventions": [ { "name": "Acetaminophen IV/PO", "type": "DRUG" }, { "name": "Acetaminophen PO", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Celebrex", "type": "DRUG" }, { "name": "Naproxen", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Gabapentin", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" }, { "name": "Opioids", "type": "DRUG" }, { "name": "Regional anesthesia", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 1561, "start_date": "2018-04-02", "completion_date": "2019-07-03", "has_results": true, "last_update_posted_date": "2021-06-18", "last_synced_at": "2026-09-06T13:03:42.859Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03472469" }, { "nct_id": "NCT03927781", "title": "Perioperative Pregabalin in Ureteroscopy: a Pilot", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Nephrolithiasis", "Urolithiasis", "Perioperative/Postoperative Complications", "Pain, Postoperative", "Pain, Acute", "Anesthesia", "Urologic Diseases", "Anesthesia Morbidity" ], "interventions": [ { "name": "Pregabalin 300mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Missouri-Columbia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2019-04-01", "completion_date": "2020-10-17", "has_results": true, "last_update_posted_date": "2021-04-19", "last_synced_at": "2026-09-06T13:03:42.859Z", "location_count": 1, "location_summary": "Columbia, Missouri", "locations": [ { "city": "Columbia", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03927781" }, { "nct_id": "NCT01314222", "title": "Diabetic Peripheral Neuropathic Pain (DPNP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Peripheral Neuropathic Pain" ], "interventions": [ { "name": "BMS-954561", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Placebo matching BMS-954561", "type": "DRUG" }, { "name": "Placebo matching Pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 178, "start_date": "2011-03", "completion_date": "2012-07", "has_results": false, "last_update_posted_date": "2015-12-07", "last_synced_at": "2026-09-06T13:03:42.859Z", "location_count": 21, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Lomita, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Lomita", "state": "California" }, { "city": "Los Gatos", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01314222" }, { "nct_id": "NCT04990804", "title": "Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Opioid Use", "Spinal Diseases", "Surgery--Complications", "Surgery", "Postoperative Pain" ], "interventions": [ { "name": "Opioid Analgesic", "type": "DRUG" }, { "name": "Opioid-Free Postoperative Pain Regimen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8, "start_date": "2021-08-01", "completion_date": "2022-02-01", "has_results": true, "last_update_posted_date": "2024-01-31", "last_synced_at": "2026-09-06T13:03:42.859Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04990804" }, { "nct_id": "NCT01309074", "title": "Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Epilepsy", "Anxiety" ], "interventions": [ { "name": "Pregabalin-Lyrica", "type": "DRUG" }, { "name": "Sertraline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rush University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 0, "start_date": "2009-11", "completion_date": "2012-12", "has_results": false, "last_update_posted_date": "2023-02-02", "last_synced_at": "2026-09-06T13:03:42.859Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01309074" }, { "nct_id": "NCT03031340", "title": "Evaluating the Role of Pregabalin in Reducing Opioid Requirement in Spinal Fusion Surgeries of Two or More Vertebrae", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Spinal Fusion" ], "interventions": [ { "name": "Pregabalin", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2012-05", "completion_date": "2012-09", "has_results": true, "last_update_posted_date": "2019-08-20", "last_synced_at": "2026-09-06T13:03:42.859Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03031340" }, { "nct_id": "NCT00524030", "title": "Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Epilepsies, Partial" ], "interventions": [ { "name": "pregabalin 600 mg/day", "type": "DRUG" }, { "name": "pregabalin 150 mg/day", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 161, "start_date": "2007-09", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2021-01-20", "last_synced_at": "2026-09-06T13:03:42.859Z", "location_count": 63, "location_summary": "Northport, Alabama • Phoenix, Arizona • Sun City, Arizona + 50 more", "locations": [ { "city": "Northport", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00524030" } ] }